Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BFNHBIOFORCE NANOSCIENCES HOLDINGS, INC.

OTC · CIK 0001310488
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3826 Laboratory Analytical Instruments
FY end1231
XBRL facts80

Identity from submissions API

NameBIOFORCE NANOSCIENCES HOLDINGS, INC.
CIK0001310488
TickersBFNH
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3826 Laboratory Analytical Instruments
EIN852138858
LEI—
Fiscal year end1231
State of incorporation—
Phone757-306-6090
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • SILVER RIVER VENTURES, INC. (2004-12-14T05:00:00.000Z → 2006-02-24T05:00:00.000Z)
Business address
2020 GENERAL BOOTH BLVD
SUITE 230
VIRGINIA BEACH
VA
23454
VA
Mailing address
2020 GENERAL BOOTH BLVD
SUITE 230
VIRGINIA BEACH
VA
23454
VA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

254 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-09 10-Q QTR. REPORT - SEPT. 30, 2026 0001091818-26-000156 000-51074 261535795 34 8681814 1 1
2026-10-07 8-K CURRENT REPORT 8.01,9.01 0001091818-26-000150 000-51074 261446051 34 2275690 1 1
2026-09-04 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001091818-26-000141 005-81683 261361694 34 8121
2026-09-04 8-K CURRENT REPORT 3.02 0001091818-26-000140 000-51074 261361320 34 179928 1 1
2026-09-04 3 PRIMARY DOCUMENT 0001091818-26-000139 4186
2026-09-03 3 PRIMARY DOCUMENT 0001091818-26-000135 3969
2026-09-02 4 PRIMARY DOCUMENT 0001091818-26-000134 7649
2026-09-02 4 PRIMARY DOCUMENT 0001091818-26-000133 8428
2026-08-18 8-K CURRENT REPORT 7.01,9.01 0001091818-26-000128 000-51074 261289790 34 9598973 1 1
2026-08-14 8-K CURRENT REPORT 8.01 0001091818-26-000124 000-51074 261280442 34 190018 1 1
2026-08-10 10-Q QTR. REPORT - JUNE 30, 2026 0001091818-26-000108 000-51074 261259287 34 10533962 1 1
2026-07-07 8-K CURRENT REPORT 8.01,9.01 0001091818-26-000089 000-51074 261158699 34 25921013 1 1
2026-07-01 8-K CURRENT REPOT 8.01,9.01 0001091818-26-000087 000-51074 261142945 34 2004257 1 1
2026-06-18 8-K CURRENT REPORT 5.01,5.02,8.01,9.01 0001091818-26-000084 000-51074 261100503 34 959778 1 1
2026-05-19 10-Q QTR. REPORT - MARCH 31, 2026 0001091818-26-000077 000-51074 26997001 34 1618025 1 1
2026-05-13 NT 10-Q NOTIFICATION OF LATE FILING 0001091818-26-000070 000-51074 26971311 34 22675
2026-04-15 10-K YEAR- END REPORT - DEC. 31, 2025 0001091818-26-000047 000-51074 26863872 34 2414461 1 1
2026-03-31 NT 10-K NOTIFICATION OF LATE FILING 0001091818-26-000032 000-51074 26817166 34 22582
2025-11-19 10-Q QTR. REPORT - SEPTEMBER 30, 2025 0001091818-25-000163 000-51074 251498050 34 1671686 1 1
2025-11-13 NT 10-Q NOTIFICATION OF LATE FILING 0001091818-25-000154 000-51074 251477772 34 22687
2025-08-11 10-Q QTR. REPORT - JUNE 30, 2025 0001091818-25-000091 000-51074 251201014 34 1602494 1 1
2025-05-13 10-Q QTR. REPORT - MARCH 31, 2025 0001091818-25-000053 000-51074 25937271 34 1510824 1 1
2025-04-08 10-K YEAR END REPORT - DEC. 31, 2024 0001091818-25-000036 000-51074 25821790 34 2331574 1 1
2025-03-28 NT 10-K NOTIFICATION OF LATE FILING 0001091818-25-000030 000-51074 25786788 34 23119
2024-11-08 10-Q QTR. REPORT - SEPT. 2024 0001091818-24-000134 000-51074 241438812 34 1687146 1 1
2024-08-07 10-Q QTR. REPORT - JUNE 30, 2024 0001091818-24-000085 000-51074 241182373 34 1467833 1 1
2024-05-07 8-K CURRENT REPORT 4.01,9.01 0001091818-24-000056 000-51074 24922354 34 188566 1 1
2024-05-03 10-Q QTR. REPORT MARCH 31, 2024 0001091818-24-000049 000-51074 24911104 34 1403531 1 1
2024-04-01 10-K YEAR- END REPORT - DEC. 31, 2023 0001091818-24-000034 000-51074 24808767 34 2296557 1 1
2023-11-03 10-Q FORM 10Q - SEPT. 30, 2023 0001091818-23-000181 000-51074 231374732 34 1550963 1 1
2023-10-18 4 PRIMARY DOCUMENT 0001091818-23-000179 8053
2023-10-18 4 PRIMARY DOCUMENT 0001091818-23-000178 5028
2023-08-01 10-Q QTR. REPORT - JUNE 30, 2023 0001091818-23-000146 000-51074 231131261 34 1505116 1 1
2023-05-09 10-Q QTR. REPORT - MARCH 31, 2023 0001091818-23-000071 000-51074 23901543 34 1403527 1 1
2023-03-28 10-K YEAR-END REPORT - DEC. 31, 2022 0001091818-23-000044 000-51074 23767647 34 2198295 1 1
2022-12-14 4 PRIMARY DOCUMENT 0001091818-22-000176 5807
2022-11-02 10-Q QTR. REPORT - SEPTEMBER 30, 2022 0001091818-22-000145 000-51074 221352854 34 1478962 1 1
2022-10-03 4 PRIMARY DOCUMENT 0001091818-22-000142 5809
2022-07-27 10-Q QTR. REPORT - JUNE 30, 2022 0001091818-22-000097 000-51074 221109984 34 1440401 1 1
2022-05-05 10-Q/A AMENDED QTR REPORT MARCH 31, 2022 0001091818-22-000045 000-51074 22895544 34 1319386 1 1
2022-05-05 10-Q bfnh-20220331.htm 0001091818-22-000041 000-51074 22895226 34 1318575 1 1
2022-02-11 10-K bfnh10k1221.htm 0001091818-22-000014 000-51074 22620150 34 2170579 1 1
2021-11-30 8-K CURRENT REPORT 5.02,9.01 0001091818-21-000150 000-51074 211459862 34 154027 1 1
2021-10-28 10-Q QUARTERLY REPORT 0001091818-21-000138 000-51074 211356713 34 1602842 1 1
2021-07-30 10-Q/A AMENDMENT NO. 1 TO QUARTERLY REPORT 0001091818-21-000101 000-51074 211133756 34 1674016 1 1
2021-07-29 10-Q QUARTERLY REPORT 0001091818-21-000099 000-51074 211126692 34 1600305 1 1
2021-06-02 8-K CURRENT REPORT 8.01 0001091818-21-000073 000-51074 21988990 34 10583
2021-04-27 10-Q QTR. REPORT -MARCH 31, 2021 0001091818-21-000055 000-51074 21858293 34 1034569 1
2021-02-16 10-K YEAR END REPORT DEC. 31, 2020 0001091818-21-000016 000-51074 21633148 34 1374587 1
2020-12-09 4/A PRIMARY DOCUMENT 0001091818-20-000273 8335
2020-12-09 4/A PRIMARY DOCUMENT 0001091818-20-000272 8191
2020-12-09 4/A PRIMARY DOCUMENT 0001091818-20-000271 8242
2020-12-07 4/A PRIMARY DOCUMENT 0001091818-20-000262 8137
2020-12-07 4/A PRIMARY DOCUMENT 0001091818-20-000261 7999
2020-12-07 4 PRIMARY DOCUMENT 0001091818-20-000260 7690
2020-12-07 4 PRIMARY DOCUMENT 0001091818-20-000259 7634
2020-12-04 8-K CURRENT REPORT 3.02 0001091818-20-000258 000-51074 201369067 34 9850
2020-10-23 10-Q QTR. REPORT - SEPT. 30, 2020 0001091818-20-000228 000-51074 201256864 34 1132387 1
2020-10-13 8-K CURRENT REPORT 8.01 0001091818-20-000211 000-51074 201234695 34 9892
2020-07-22 10-Q QTR. REPORT - JUNE 30, 2020 0001091818-20-000170 000-51074 201041535 34 1281328 1
2020-07-14 8-K CURRENT REPORT 8.01 0001091818-20-000158 000-51074 201026617 34 10617
2020-07-09 8-K/A AMENDED: CHANGED WORD "FORMERLY" WITH "FORMALLY" 8.01 0001091818-20-000152 000-51074 201019889 34 9573
2020-07-09 8-K CURRENT REPORT 8.01 0001091818-20-000150 000-51074 201019847 34 9100
2020-05-18 8-K CURRENT REPORT 8.01 0001091818-20-000129 000-51074 20888750 34 9326
2020-05-04 10-Q QTR. REPORT -MARCH 31, 2020 0001091818-20-000107 000-51074 20843494 34 1222029 1
2020-04-02 4 PRIMARY DOCUMENT 0001091818-20-000079 5464
2020-04-02 4 PRIMARY DOCUMENT 0001091818-20-000078 5399
2020-04-01 8-K CURRENT REPORT 3.02 0001091818-20-000077 000-51074 20764764 34 9508
2020-03-09 10-K/A AMENDED YEAR- END REPORT- DEC.31, 2019 0001091818-20-000039 000-51074 20696602 34 1449810 1
2020-03-04 10-K YEAR - END REPORT-DEC.31, 2019 0001091818-20-000036 000-51074 20685670 34 1449255 1
2019-12-31 UPLOAD filename1.pdf 0000000000-19-016880 39706
2019-12-31 DEFR14C REVISED DEFINITIVE INFORMATION STATEMENT NO. 2 INCLUDES EXHIBITS 0001091818-19-000353 000-51074 191318472 34 91314
2019-12-31 DEFR14C REVISED DEFINITIVE INFORMATION STATEMENT 0001091818-19-000351 000-51074 191317582 34 41474
2019-12-31 DEF 14C DEFINITIVE INFORMATION STATEMENT 0001091818-19-000349 000-51074 191317551 34 41494
2019-12-27 CORRESP filename1.htm 0001091818-19-000340 7982
2019-12-27 PRER14C REVISED PRELIMINARY INFO. STATEMENT 0001091818-19-000339 000-51074 191312732 34 91295
2019-12-23 UPLOAD filename1.pdf 0000000000-19-016716 42069
2019-12-13 PRE 14C PRELIMINARY INFORMATION STATEMENT 0001091818-19-000322 000-51074 191283867 34 85590
2019-11-05 10-Q QTR. ENDING SEPT. 30, 2019 0001091818-19-000265 000-51074 191193203 34 1030748 1
2019-07-22 10-Q QTR. ENDING JUNE 30, 2019 0001091818-19-000192 000-51074 19965078 34 1022889 1
2019-04-30 10-Q QTR. MARCH 31, 2019 0001091818-19-000131 000-51074 19779950 34 884035 1
2019-03-29 10-K YEAR END REPORT- DECEMBER 31, 2018 0001091818-19-000088 000-51074 19713250 34 1418173 1
2018-10-24 10-Q QTR. REPORT-SEPT. 30, 2018 0001091818-18-000190 000-51074 181136425 34 877478 1
2018-08-10 3 PRIMARY DOCUMENT 0001091818-18-000157 4033
2018-08-10 3 PRIMARY DOCUMENT 0001091818-18-000156 3882
2018-08-10 3 PRIMARY DOCUMENT 0001091818-18-000155 4778
2018-08-01 UPLOAD filename1.pdf 0000000000-18-023819 35844
2018-07-27 10-12G/A AMENDED REGISTRATION STATEMENT 0001091818-18-000152 000-51074 18973924 34 677736
2018-07-24 10-Q QTR. REPORT_JUNE 30, 2018 0001091818-18-000150 000-51074 18966366 34 169060
2018-06-28 CORRESP filename1.htm 0001091818-18-000132 686905
2018-06-28 10-12G/A AMENDED REGISTRATION STATEMENT 0001091818-18-000131 000-51074 18924302 34 678390
2018-06-19 UPLOAD filename1.pdf 0000000000-18-018764 77606
2018-05-25 CORRESP filename1.htm 0001091818-18-000112 697505
2018-05-25 10-12G/A AMENDED REGISTRATION STATEMENT 0001091818-18-000111 000-51074 18861439 34 677422
2018-05-16 UPLOAD filename1.pdf 0000000000-18-015139 175553
2018-05-11 10-Q QTR. REPORT- MARCH 31, 2018 0001091818-18-000096 000-51074 18827461 34 160725
2018-04-25 CORRESP filename1.htm 0001091818-18-000084 730325
2018-04-25 10-12G/A AMENDED REGISTRATION STATEMENT 0001091818-18-000083 000-51074 18774245 34 699415
2018-04-13 10-K YEAR END REPORT- DECEMBER 31, 2017 0001091818-18-000078 000-51074 18754059 34 553018
2018-03-29 NT 10-K NOTIFICATION OF LATE FILING 0001091818-18-000062 000-51074 18723178 34 22531
2018-03-15 UPLOAD filename1.pdf 0000000000-18-008070 189511
2018-02-28 CORRESP filename1.htm 0001091818-18-000030 698440
2018-02-28 10-12G/A AMENDED REGISTRATION STATEMENT 0001091818-18-000029 000-51074 18649174 34 678729
2018-02-13 UPLOAD filename1.pdf 0000000000-18-005012 235361
2018-01-26 CORRESP filename1.htm 0001091818-18-000014 729541
2018-01-26 10-12G/A AMENDED REGISTRATION 0001091818-18-000013 000-51074 18550562 34 4156703
2018-01-12 UPLOAD filename1.pdf 0000000000-18-001283 187313
2017-12-19 10-12G REGISTRATION STATEMENT 0001091818-17-000250 000-51074 171263913 34 2336574
2017-03-02 8-K CURRENT REPORT 8.01 0001091818-17-000029 000-51074 17657754 34 7663
2009-04-14 15-12G NOTICE OF TERMINATION OF REGISTRATION 0001091818-09-000112 000-51074 09748957 34 7246
2009-03-31 NT 10-K NOTIFICATION OF LATE FILING 0001091818-09-000103 000-51074 09719810 34 23713
2009-03-17 8-K CURRENT REPORT 1.01,2.04,9.01 0001091818-09-000078 000-51074 09688667 34 33069
2009-03-17 4 PRIMARY DOCUMENT 0001091818-09-000076 11873
2009-03-17 4 PRIMARY DOCUMENT 0001091818-09-000075 11850
2009-03-17 4 PRIMARY DOCUMENT 0001091818-09-000074 11858
2009-02-06 8-K CURRENT REPORT 2.04,9.01 0001091818-09-000041 000-51074 09578016 34 16315
2009-01-16 4 PRIMARY DOCUMENT 0001091818-09-000021 7723
2009-01-16 4 PRIMARY DOCUMENT 0001091818-09-000020 7738
2009-01-16 4 PRIMARY DOCUMENT 0001091818-09-000019 7716
2009-01-15 8-K CURRENT REPORT 7.01,9.01 0001091818-09-000014 000-51074 09528329 34 4588061
2008-12-17 4 PRIMARY DOCUMENT 0001091818-08-000387 7730
2008-12-17 4 PRIMARY DOCUMENT 0001091818-08-000386 7739
2008-12-17 4 PRIMARY DOCUMENT 0001091818-08-000385 7739
2008-11-24 4 PRIMARY DOCUMENT 0001091818-08-000378 12424
2008-11-21 4 PRIMARY DOCUMENT 0001091818-08-000375 12439
2008-11-21 4 PRIMARY DOCUMENT 0001091818-08-000374 12522
2008-11-21 4 PRIMARY DOCUMENT 0001091818-08-000373 7994
2008-11-21 4 PRIMARY DOCUMENT 0001091818-08-000372 10299
2008-11-21 4 PRIMARY DOCUMENT 0001091818-08-000371 7924
2008-11-20 8-K CURRENT REPORT 1.01,3.02,5.01,9.01 0001091818-08-000362 000-51074 081203141 34 313814
2008-11-17 4 PRIMARY DOCUMENT 0001091818-08-000350 5643
2008-11-17 4 PRIMARY DOCUMENT 0001091818-08-000349 5636
2008-11-17 4 PRIMARY DOCUMENT 0001091818-08-000348 5649
2008-11-14 10-Q QUARTERLY REPORT 0001091818-08-000337 000-51074 081189014 34 348297
2008-11-12 8-K CURRENT REPORT 5.02,9.01 0001091818-08-000330 000-51074 081178165 34 26731
2008-10-17 4 PRIMARY DOCUMENT 0001091818-08-000322 5648
2008-10-17 4 PRIMARY DOCUMENT 0001091818-08-000321 5652
2008-10-17 4 PRIMARY DOCUMENT 0001091818-08-000320 5638
2008-09-23 4 PRIMARY DOCUMENT 0001091818-08-000290 5592
2008-09-23 4 PRIMARY DOCUMENT 0001091818-08-000289 5651
2008-09-23 4 PRIMARY DOCUMENT 0001091818-08-000288 5645
2008-09-19 424B3 PROSPECTUS 0001091818-08-000285 333-146427 081079731 33 351089
2008-09-18 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001091818-08-000266,2008-09-18 9999999995-08-002865 333-146427 081079331 33 2227
2008-09-09 POS AM POST EFFECTIVE AMENDMENT 0001091818-08-000266 333-146427 081062972 33 390839
2008-08-29 UPLOAD filename1.pdf 0000000000-08-043623 41561
2008-08-29 10-Q/A AMENDED QTR. REPORT 0001091818-08-000258 000-51074 081047128 34 38612
2008-08-28 10QSB/A AMENDED QTR. REPORT 0001091818-08-000256 000-51074 081045892 34 38833
2008-08-27 10KSB/A AMENDED YEAR END FILING 0001091818-08-000252 000-51074 081041971 34 1298773
2008-08-26 CORRESP filename1.htm 0001091818-08-000250 92613
2008-08-14 10-Q QUARTERLY REPORT 0001091818-08-000220 000-51074 081019650 34 279047
2008-08-13 8-K CURRENT REPORT 1.01,5.02,9.01 0001091818-08-000213 000-51074 081013062 34 174747
2008-07-24 8-K CURRENT REPORT 1.01,3.02,9.01 0001091818-08-000193 000-51074 08967191 34 324716
2008-07-23 SC 13D/A e604038_sc13da-sgamai.txt 0001193805-08-001750 005-81683 08964931 34 15592
2008-07-23 4 xslF345X03/e604037_ex.xml 0001193805-08-001749 7994
2008-07-22 UPLOAD filename1.pdf 0000000000-08-036491 88103
2008-07-16 4 xslF345X03/e604028_ex.xml 0001193805-08-001731 5511
2008-07-11 POS AM e604022_posam-bioforce.txt 0001193805-08-001724 333-146427 08948925 33 376588
2008-06-20 SC 13D/A e603968_sc13da-sgamai.txt 0001193805-08-001598 005-81683 08909949 34 16518
2008-06-20 SC 13D/A e603965_sc13da-henderson.txt 0001193805-08-001591 005-81683 08908895 34 15680
2008-06-16 8-K e603957_8k-bioforce.txt 1.01,3.02,9.01 0001193805-08-001574 000-51074 08899748 34 209390
2008-06-12 4 xslF345X02/e603948_ex.xml 0001193805-08-001559 7713
2008-06-12 4 FORM 4 0001193805-08-001557 8018
2008-06-12 4 xslF345X02/e603950_ex.xml 0001193805-08-001555 7642
2008-06-12 4 xslF345X02/e603949_ex.xml 0001193805-08-001553 7638
2008-05-15 10QSB e603825_10qsb-bioforce.htm 0001193805-08-001350 000-51074 08834424 34 855623
2008-04-14 DEF 14A e603660_def14a-bioscience.htm 0001193805-08-001098 000-51074 08753584 34 468675
2008-03-31 10KSB e603584_10ksb-bioforce.htm 0001193805-08-000969 000-51074 08723065 34 1447939
2008-02-04 8-K FORM 8-K 7.01,9.01 0001193805-08-000184 000-51074 08571406 34 2172731
2008-01-25 8-K FORM 8-K 5.02,8.01,9.01 0001193805-08-000143 000-51074 08549277 34 10798
2007-11-21 8-K e602883_8k-bioforce.txt 2.02,8.01,9.01 0001193805-07-002954 000-51074 071262588 34 22799
2007-11-14 10QSB e602834_10qsb-bioforce.htm 0001193805-07-002884 000-51074 071246513 34 1492135
2007-10-15 424B3 FORM 424B3 0001193805-07-002615 333-146427 071170963 33 356876
2007-10-12 EFFECT xslEFFECTX01/primary_doc.xml SB-2,,2007-10-12 16:00:00 9999999995-07-004044 333-146427 071170858 33 2215
2007-10-12 SB-2/A e602704_sb2a-bnh.txt 0001193805-07-002611 333-146427 071169660 33 398583
2007-10-03 3 FORM 3 0001193805-07-002521 7745
2007-10-01 SB-2 FORM SB-2 0001193805-07-002504 333-146427 071146840 33 408600
2007-09-07 8-K e602595_8k-bioforce.txt 1.01,3.02,5.03,9.01 0001193805-07-002379 000-51074 071107049 34 859123
2007-08-14 10QSB e602444_10qsb-bioforce.txt 0001193805-07-002054 000-51074 071051493 34 206293
2007-08-10 8-K e602447_8k-bioforce.txt 2.02,9.01 0001193805-07-002037 000-51074 071044826 34 23532
2007-06-27 8-K LIVE FILING 7.01,9.01 0001299933-07-003861 000-51074 07942625 34 17853
2007-06-19 8-K LIVE FILING 5.02,8.01,9.01 0001299933-07-003728 000-51074 07928497 34 17779
2007-06-15 4 FORM 4 SUBMISSION 0001209191-07-037276 5935
2007-06-15 4 FORM 4 SUBMISSION 0001209191-07-037275 5983
2007-06-15 4 FORM 4 SUBMISSION 0001209191-07-037271 6007
2007-06-15 4 FORM 4 SUBMISSION 0001209191-07-037270 5917
2007-06-15 3/A FORM 3/A SUBMISSION 0001209191-07-037267 5131
2007-06-15 3/A FORM 3/A SUBMISSION 0001209191-07-037263 10341
2007-06-15 3/A FORM 3/A SUBMISSION 0001209191-07-037260 6503
2007-06-15 3/A FORM 3/A SUBMISSION 0001209191-07-037257 6485
2007-05-25 8-K CURRENT REPORT 7.01,9.01 0001193805-07-001400 000-51074 07880539 34 2976397
2007-05-15 10QSB FORM 10-QSB 0001193805-07-001309 000-51074 07849376 34 82105
2007-05-14 8-K CURRENT REPORT 2.02,9.01 0001193805-07-001296 000-51074 07846926 34 22618
2007-04-03 UPLOAD filename1.pdf 0000000000-07-016501 15556
2007-04-02 10KSB FORM 10-KSB 0001193805-07-000928 000-51074 07735142 34 721895
2007-03-23 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001193805-07-000860 005-81683 07713174 34 15891
2007-03-14 CORRESP filename1.txt 0000931731-07-000025 10440
2007-03-14 8-K/A BIOFORCE 8KA 031307 4.02 0000931731-07-000024 000-51074 07693541 34 7214
2007-03-09 8-K CURRENT REPORT 7.01,9.01 0001193805-07-000748 000-51074 07683397 34 22334418
2007-02-05 4 xslF345X02/form4-frey04112006_ex.xml 0000931731-07-000016 5798
2007-02-05 3 xslF345X02/form3-frey_ex.xml 0000931731-07-000015 7900
2007-02-05 3/A xslF345X02/form3a-lgold022406_ex.xml 0000931731-07-000014 9459
2007-02-05 3/A xslF345X02/form3a-jjsunier_ex.xml 0000931731-07-000013 9474
2007-02-05 4 xslF345X02/form4-ehenderson113006_ex.xml 0000931731-07-000012 6160
2007-02-05 3/A FORM 3A - EHENDERSON 022406 0000931731-07-000011 11591
2007-01-29 UPLOAD filename1.pdf 0000000000-07-004492 25764
2007-01-24 3 xslF345X02/form3-brown_ex.xml 0000931731-07-000004 7944
2007-01-16 8-K BIOF 8-K 011607 5.02,7.01 0000931731-07-000002 000-51074 07532695 34 19071
2006-11-17 10QSB BIOF 10QSB 093006 0000931731-06-000252 000-51074 061227060 34 62632
2006-11-17 10QSB/A BIOF 10QSBA 093006 0000931731-06-000251 000-51074 061227058 34 64361
2006-11-15 NT 10-Q BIOF NT 10Q 093006 0000931731-06-000248 000-51074 061219116 34 7422
2006-11-14 8-K/A BIOF 8KA 111306 9.01 0000931731-06-000238 000-51074 061210952 34 69322
2006-11-13 CORRESP filename1.txt 0000931731-06-000239 6240
2006-11-09 10QSB/A BIOF 10QSB-A 033106 0000931731-06-000234 000-51074 061201997 34 59394
2006-10-27 CORRESP filename1.txt 0000931731-06-000228 4051
2006-10-06 8-K BIOFORCE 8K 100506 5.02,9.01 0000931731-06-000215 000-51074 061132188 34 9143
2006-09-26 8-K BIOFORCE 8K 092606 7.01,9.01 0000931731-06-000207 000-51074 061109550 34 14071
2006-09-14 UPLOAD filename1.pdf 0000000000-06-044345 28352
2006-08-11 10QSB BIOFORCE 10QSB 063006 0000931731-06-000159 000-51074 061025688 34 120666
2006-08-07 10QSB/A BIOFORCE 10QSBA 033106 0000931731-06-000153 000-51074 061010050 34 315292
2006-08-07 8-K BIOFORCE 8K 080706 XCPA 4.01,9.01 0000931731-06-000152 000-51074 061009572 34 9082
2006-08-07 8-K BIOFORCE 8K 080706 4.01,9.01 0000931731-06-000151 000-51074 061009437 34 10175
2006-08-07 8-K/A BIOFORCE 8K AMENDED 080706 9.01 0000931731-06-000150 000-51074 061009418 34 68668
2006-07-12 UPLOAD filename1.pdf 0000000000-06-032333 35215
2006-05-22 10QSB BIOFORCE 10QSB 033106 0000931731-06-000112 000-51074 06857501 34 55013
2006-05-16 NT 10-Q BIOFORCE-NT10Q - 033106 0000931731-06-000105 000-51074 06844878 34 7795
2006-04-17 10KSB BIOFORCE 10KSB 123105 0000931731-06-000083 000-51074 06762835 34 188128
2006-04-03 NT 10-K BIOFORCE NT 10K 123105 0000931731-06-000071 000-51074 06732642 34 8087
2006-03-20 SC 13D SC 13D - EHENDERSON 0000931731-06-000051 005-81683 06697898 34 137292
2006-03-20 SC 13D SC 13D - SGAMAI 0000931731-06-000050 005-81683 06697897 34 138696
2006-03-13 3 FORM 3 - LGOLD 022406 0000931731-06-000046 9375
2006-03-13 3 FORM 3 - JSUNIER 022406 0000931731-06-000045 9398
2006-03-13 3 FORM 3 - EHENDERSON 022406 0000931731-06-000044 8760
2006-03-13 3 xslF345X02/form3-sgam022406_ex.xml 0000931731-06-000043 7970
2006-03-02 8-K BIOFORCE 8K - 030206 2.01,9.01 0000931731-06-000034 000-51074 06660137 34 324501
2006-02-24 8-K BIOFORCE 8K 022406 7.01 0000931731-06-000033 000-51074 06643325 34 6307
2006-01-12 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-06-004008 021-85819 06021058 34 1763
2006-01-10 DEF 14C SRVV DEF 14C 0000931731-06-000002 000-51074 06522319 34 350887
2005-12-29 PRE 14C SRVV PRE 14C 0000931731-05-000273 000-51074 051292133 34 351197
2005-12-22 3 xslF345X02/form3-rpc_ex.xml 0000931731-05-000270 3963
2005-12-22 3 xslF345X02/form3-hnk122205_ex.xml 0000931731-05-000268 3850
2005-12-20 3 xslF345X02/form3-hdeworthwms121605_ex.xml 0000931731-05-000266 3889
2005-12-19 4/A xslF345X02/form4-efcowle121605_ex.xml 0000931731-05-000265 5062
2005-12-16 4 xslF345X02/form4-efcowle121605_ex.xml 0000931731-05-000264 4771
2005-12-01 8-K SILVER RIVER 8K 120105 1.01,9.01 0000931731-05-000256 000-51074 051238355 34 119061
2005-11-15 NT 10-Q SILVER RIVER NT 10Q 093005 0000931731-05-000225 000-51074 051204159 34 6969
2005-11-14 10QSB SILVER RIVER 10QSB 093005 0000931731-05-000228 000-51074 051204181 34 41139
2005-10-24 8-K SILVER RIVER 8K XCPA 4.01,9.01 0000931731-05-000201 000-51074 051151436 34 8642
2005-08-12 10QSB SILVER RIVER 10QSB 063005 0000931731-05-000147 000-51074 051018639 34 48848
2005-05-11 10QSB SILVER RIVER 10QSB 033105 0000931731-05-000082 000-51074 05819408 34 47788
2005-03-31 10KSB SILVER RIVER 10KSB 123104 0000931731-05-000057 000-51074 05715553 34 124570
2005-01-19 CORRESP filename1.txt 0000931731-05-000008 5939
2005-01-19 10SB12G/A SILVER RIVER AMEND #1 0000931731-05-000007 000-51074 05535489 34 131868
2005-01-05 UPLOAD filename1.txt 0000000000-05-000964 5446
2004-12-14 10SB12G SILVER RIVER VENTURES 10SB DEC 04 0000931731-04-000367 000-51074 041199732 34 169886

Latest XBRL company facts

One latest value per concept from companyfacts (80 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 38.07M 2026-11-06 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
dei EntityPublicFloat Entity Public Float USD 2.63M 2025-06-30 2025 FY 10-K 2026-04-15 0001091818-26-000047
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 11,836 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 5,735 2018-12-31 2019 FY 10-K/A 2020-03-09 0001091818-20-000039
us-gaap AccruedSalariesCurrentAndNoncurrent Accrued Salaries USD 506,203 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 161.76M 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap Assets Assets USD 786 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap AssetsCurrent Assets, Current USD 786 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap Cash Cash USD 605 2020-06-30 2020 Q2 10-Q 2020-07-22 0001091818-20-000170
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 786 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -13,030 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-16 0001091818-21-000016
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 31,696 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -10,355 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001091818-22-000145
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 30,910 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 900.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 38.07M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 38.07M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap CommonStockValue Common Stock, Value, Issued USD 33,522 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap CompensationExpenseExcludingCostOfGoodAndServiceSold Compensation Expense, Excluding Cost of Good and Service Sold USD 283,250 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 1,167 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-11 0001091818-22-000014
us-gaap CostOfRevenue Cost of Revenue USD 13,415 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-16 0001091818-21-000016
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 12,555 2019-01-01 2019-12-31 2019 FY 10-K/A 2020-03-09 0001091818-20-000039
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 30,855 2019-12-31 2019 FY 10-K/A 2020-03-09 0001091818-20-000039
us-gaap DueFromBanks Due from Banks USD 39,260 2020-06-30 2020 Q2 10-Q 2020-07-22 0001091818-20-000170
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 164,681 2022-09-30 2022 Q3 10-Q 2022-11-02 0001091818-22-000145
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.02 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-11 0001091818-22-000014
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K/A 2020-03-09 0001091818-20-000039
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 802,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 438,494 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap GrossProfit Gross Profit USD 4,360 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-16 0001091818-21-000016
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -721,744 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2019-01-01 2019-12-31 2019 FY 10-K/A 2020-03-09 0001091818-20-000039
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 48,180 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -5,735 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-16 0001091818-21-000016
us-gaap IncreaseDecreaseInAccruedSalaries Increase (Decrease) in Accrued Salaries USD 110,500 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 17,500 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 13,255 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-10-23 0001091818-20-000228
us-gaap Liabilities Liabilities USD 619,329 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 786 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap LiabilitiesCurrent Liabilities, Current USD 619,329 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 145,592 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -114,682 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -205,410 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -341,680 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 516,334 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap OperatingExpenses Operating Expenses USD 721,744 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -372,153 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-19 0001091818-25-000163
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 114,200 2019-12-31 2019 FY 10-K/A 2020-03-09 0001091818-20-000039
us-gaap OtherExpenses Other Expenses USD 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.94M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 1,000 2020-05-01 2020-05-06 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2020-09-30 2020 Q3 10-Q 2020-10-23 0001091818-20-000228
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2021-12-31 2022 Q1 10-Q 2022-05-05 0001091818-22-000041
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 100 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001091818-22-000145
us-gaap ProceedsFromContributionsFromParent Proceeds from Contributions from Parent USD 100 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-03 0001091818-23-000181
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 1,339 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-11 0001091818-22-000014
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 65,074 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001091818-26-000047
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 143,592 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -1.17M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-19 0001091818-25-000163
us-gaap RepaymentsOfDebt Repayments of Debt USD 1,527 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 4.25M 2025-01-02 2025-01-24 2026 Q2 10-Q 2026-08-10 0001091818-26-000108
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -162.41M 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap Revenues Revenues USD 17,775 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-16 0001091818-21-000016
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 158.00M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-23 0001091818-20-000228
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.79 2021-12-31 2021 FY 10-K 2022-02-11 0001091818-22-000014
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -618,543 2026-12-31 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 100,000 2020-05-01 2020-05-06 2023 Q3 10-Q 2023-11-03 0001091818-23-000181
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 4.25M 2025-01-02 2025-01-24 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 8,075 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-15 0001091818-26-000047
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 100 2022-07-01 2022-09-30 2023 Q3 10-Q 2023-11-03 0001091818-23-000181
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 2.17M 2025-01-02 2025-01-24 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 34.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 29.27M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-11 0001091818-22-000014
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 34.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001091818-26-000156

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →